© 2001 by European Society of Cardiology
Copyright © 2001, European Society of Cardiology
Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep
Department of Physiology, Pharmacology and Biochemistry. Favaloro University, Solis 453, 1078 Buenos Aires, Argentina
* Corresponding author. Tel.: +54-1-14378-1185-1187; fax: +54-1-14381-0323 delvalle{at}favaloro.edu.ar
Introduction: Sulfonylureas have been associated with a high incidence of cardiovascular death in diabetic patients treated with these drugs. Although the evidence on the cardiovascular effects of sulfonylureas is contradictory and scarce, many experiments have shown that the second-generation compound glibenclamide has a protective effect on mechanical function and against generation of malignant arrhythmias. Objective: The purpose of this study was to assess whether glibenclamide elicits protection on postischemic myocardial functional recovery (stunning) and against reperfusion-induced arrhythmias in a conscious sheep model. Methods: Sheep were divided into three groups: control, glibenclamide (0.4 mg/kg) and vehicle. After a 12-min ischemic period, the heart was reperfused and recordings for index calculation were acquired during 2 h of reperfusion. Percent systolic wall thickening fraction (%WTH), radial diastolic compliance (CR), arrhythmia incidence and Bernauer's arrhythmia severity index (ASI) were calculated for each group. Results: Glibenclamide infusion had a high proarrhythmic action (ASI: glibenclamide 143, control 54 and vehicle 23; ANOVA P<0.001 drug vs. control and vehicle) and a detrimental effect on regional systolic (%WTH: glibenclamide 26.9±6.7, control 65.7±3.5 and vehicle 68.6±5.6, ANOVA P<0.01 drug vs. control and vehicle) and diastolic function (CR: glibenclamide 76.2±7.8, control 104.7±4.2 and vehicle 106±4.9, ANOVA P<0.05 drug vs. control and vehicle) during reperfusion. Conclusions: Glibenclamide infusion resulted in adverse cardiovascular effects. The combined deleterious effects on reperfusion-induced arrhythmias and on myocardial recovery from stunning could be the cause of the unexplained high mortality in diabetic patients treated with sulfonylurea derivatives. The mechanism involved seems to be the blockade of the cardiac ATP sensitive potassium (K-ATP) channel.
KEYWORDS Ischemia; K-ATP channel; Reperfusion; Stunning; Ventricular arrhythmias; Ventricular function
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. P. Laguens, A. J. Lazarowski, L. A. Cuniberti, G. L. Vera Janavel, P. M. Cabeza Meckert, G. G. Yannarelli, H. F. del Valle, E. C. Lascano, J. A. Negroni, and A. J. Crottogini Expression of the MDR-1 Gene-encoded P-glycoprotein in Cardiomyocytes of Conscious Sheep Undergoing Acute Myocardial Ischemia Followed by Reperfusion J. Histochem. Cytochem., February 1, 2007; 55(2): 191 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Lee and C. O. Lee Inhibition of Na+-K+ Pump and L-Type Ca2+ Channel by Glibenclamide in Guinea Pig Ventricular Myocytes J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 61 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F del Valle, E. C Lascano, and J. A Negroni Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels Cardiovasc Res, August 15, 2002; 55(3): 642 - 659. [Abstract] [Full Text] [PDF]
|
|